June 13, 2017
Drug Discovery News: Special Report on Cancer Metabolomics- Into the metabolic maelstrom
Learn More >>

March 27, 2017
BioWorld: Next-generation oncology: New technologies and MOAs
Learn More >>

March 24, 2017
BIOCENTURY: How Cornerstone’s CPI-613 leapfrogged to pivotal trials in AML and pancreatic cancer
Learn More >>

March 23, 2017
MedCity News: Cornerstone gets green light for two pivotal cancer trials
Learn More >>

March 17, 2017
PM 360 Movers and Shakers: Chi Van Dang, M.D., Ph.D., appointed to Cornerstone’s Board of Directors. Will also serve as Chair of its Scientific and Medical Advisory Boards
Learn More >>

February 14, 2017
WCTC-AM: Interview with Sanjeev Luther (COO, Cornerstone Pharmaceuticals)
Learn More >>

February 8, 2017
FirstWorld Pharma: Cornerstone Pharmaceuticals Announces the Addition of World-Renowned Experts to Scientific and Medical Advisory Boards
Learn More >>

January 30, 2017
BioWorld Appointments and Advancements:- Cornerstone’s new Board of Directors (Subscription Required)
Learn More >>

January 16, 2017
The Price of Business Radio: JP Morgan Biotech, Sanjeev Luther (COO, Cornerstone Pharmaceuticals) and Tim Pardee (Chief Oncologist, Cornerstone Pharmaceuticals) on CPI-613
Learn More >>

January 14, 2017
Vital Options International: Dr Timothy Pardee at ASH 2016- Addressing patients participating in clinical trials
Learn More >>

January 14, 2017
Vital Options International: Dr Timothy Pardee at ASH 2016- New Therapeutic Methods
Learn More >>

January 14, 2017
Vital Options International: Dr Zanetta Lamar at ASH 2016- The cost of therapy and quality of care
Learn More >>

January 14, 2017
Vital Options International: Dr Zanetta Lamar at ASH 2016- The data collected by Wake Forest Baptist Health
Learn More >>

December 5, 2016
ecancer: Dr Timothy Pardee at ASH 2016 on TCA cycle inhibition by CPI-613 in older AML patients
Learn More >>

December 5, 2016
ecancer: Dr Zanetta Lamar at ASH 2016 on dose escalation of CPI-613 with bendamustine for relapsed T Cell NHL
Learn More >>

January 09, 2015
OncLive: Dr. Powell at ASH 2014 on CPI-613, Cytarabine, Mitoxantrone Combo for AML
Learn More >>
September 11, 2014
OncLive: Dr. Pardee on CPI-613 for Patients With R/R AML
Learn More >>
December 20, 2013
OncLive: Dr. Pardee Provides an Update on CPI-613 in advanced hematologic malignancies
Learn More >>

November 01, 2013
BioWorld Today: Clinic Roundup (subscription required)
Learn More >>

November 01, 2013
Drug Development Technology: Cornerstone begins Phase II study of pancreatic cancer drug
Learn More >>

November 01, 2013
Pharmaceutical Business Review: Cornerstone initiates Phase II trial of CPI-613 to treat metastatic pancreatic cancer patients
Learn More >>

October 28, 2013
Drug Development Technology: Cornerstone begins Phase II trial of lung cancer drug
Learn More >>

October 17, 2013
BioPharma International: Cornerstone Pharmaceuticals Receives FDA Orphan Drug Designation
Learn More >>

October 11, 2013
LymphomaInfo.net: Cornerstone Gets Orphan Drug Status For MDS Treatment
Learn More >>

October 07, 2013
Medical News Today: Cornerstone Pharmaceuticals receives FDA orphan drug designation of CPI-613 for treatment of myelodysplastic syndrome
Learn More >>

October 04, 2013
Hematology Times: Drug gets orphan designation for MDS (Registration Required)
Learn More >>

October 03, 2013
The MDS Beacon: Cornerstone Pharmaceuticals Receives FDA Orphan Drug Designation Of CPI-613 For Treatment Of Myelodysplastic Syndrome
Learn More >>

October 03, 2013
Oncology Times: FDA Grants MDS Drug CPI-613 Orphan Drug Status
Learn More >>

July 25, 2013
OncLive: Dr. Powell Discusses the Next Steps for CPI-613
Learn More >>

July 10, 2013
OncLive: Dr. Pardee on CPI-613 in Hematologic Malignancies
Learn More >>

June 11, 2013
OncLive: Dr. Powell Discusses CPI-613 in Hematologic Malignancies
Learn More >>

December 14, 2011
Drug Discovery & Development: Cornerstone Releasing CPI-613 Data
Learn More >>

December 13, 2011
BioWorld Today: ASH Roundup (subscription required)
Learn More >>

December 06, 2011
Drug Discovery & Development: On Target Delivery
Learn More >>

August 15, 2011
BioCentury: Powering down cancer
Learn More >>

August 01, 2011
BioWorld Today: Bench Press (subscription required)
Learn More >>

November 29, 2010
The New York Times: Fuel lines of tumors are new target
Learn More >>

September 2010
Start-Up Magazine: Profile on Cornerstone Pharmaceuticals
Learn More >>

August 2010
Drug Discovery News: Trends in cancer research
Learn More >>

May 2010
Drug Discovery News: Cancer research turns a corner
Learn More >>